| Value | ₹326.1 Cr |
|---|
BSE filing, NSE: INDOSTAR. Summary written from the filing by ALFA Finder's alert engine.
Indostar Capital Finance Ltd: key numbers
- Share price
- ₹184.72
- Market cap
- ₹2,986 Cr
- Revenue (annual)
- ₹1,393 Cr
- Net profit (annual)
- ₹140.4 Cr
- P/E (TTM)
- -7.6×Sector 19.1×
- Promoter holding
- 70.33%-0.03% QoQ
- FII holding
- 2.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indostar Capital Finance Ltd
All →Indostar Capital Finance Investor Presentation: Key Takeaways
Q2FY27 PAT ₹13.1 Cr (vs ₹10.5 Cr YoY), AUM ₹8,459 Cr (+11.8% YoY), NIM 8.9%, CAR 36.0%. Vehicle finance core; Micro LAP scaling.
Indostar Capital Finance Results Update
IndoStar reported Q2 FY27 standalone results, with disbursements up 51% YoY to ₹1,399 crore. Profit after tax rose to ₹13.1 crore and AUM reached ₹8,459 crore.
Indostar Capital Finance Management Change
IndoStar Capital's Company Secretary and Compliance Officer Shikha Jain resigned effective 29 October 2026. Reshma Ramchandani was appointed in her place from 30 October 2026.
Indostar Capital Finance Q2 FY27 Results: Net Profit ₹13.2 Cr, Up 25.7% YoY
Indostar Capital Finance Ltd reported revenue from operations of ₹382 Cr (+7.1% YoY) and net profit of ₹13.2 Cr (+25.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹13.2 Cr · +25.7% YoY
Indostar Capital Finance Board Meeting Date
IndoStar Capital Finance has scheduled a board meeting on October 29, 2026, to consider and approve its unaudited financial results for the quarter ending September 30, 2026.
Indostar Capital Finance Other Announcement
Indostar Capital Finance Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026. This is a mandatory compliance disclosure under SEBI regulations.
Other results update announcements
All →Aatmaj Healthcare Results Update
Aatmaj Healthcare reported H1 FY27 revenue of Rs. 16.96 crore and EBITDA of Rs. 2.04 crore. The company targets 80% revenue growth for FY27.
RPG Life Sciences Results Update
RPG Life Sciences reported Q2 FY27 revenue of ₹211.6 crore, growing 16.5%, and adjusted EBITDA of ₹50.1 crore. The API business integration continues to progress.
Praruh Technologies Results Update
Praruh Technologies reported strong H1 FY27 growth, with revenue rising 378% YoY to ₹84.06 Crore and PAT increasing 733% to ₹8.18 Crore.
CARE Ratings Results Update
CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.
EPACK Durables Results Update
EPACK Durable reported record first-half revenue and strong Q2 FY27 growth. The board also approved exiting its EPAVO joint venture stake.
3i Infotech Results Update
3i Infotech reported Q2FY27 revenue of Rs.182.0 crore, up 4.1% year-on-year. Quarterly PAT stood at Rs.6.7 crore and 25 new client wins were added.